Alternative and complementary therapies: Glucosamine/Chondroitin: Still waiting for an answer

Esther Y. Dell; Suzanne M. Shultz

doi:10.1300/J381v10n04_09

Alternative and complementary therapies: Glucosamine/Chondroitin: Still waiting for an answer

Esther Y. Dell
, Suzanne M. Shultz

Harrell Health Sciences Library - Hershey

Research output: Contribution to journal › Article › peer-review

Abstract

Results of the four-year study entitled the Glucosamine/chondroitin Arthritis Intervention Trial (GAIT) provided partial answers to those seeking relief from arthritis pain. Scientists will continue studying the efficacy of these substances as pain remedy and cartilage rejuvenator.

Original language	English (US)
Pages (from-to)	95-101
Number of pages	7
Journal	Journal of Consumer Health on the Internet
Volume	10
Issue number	4
DOIs	https://doi.org/10.1300/J381v10n04_09
State	Published - 2006

All Science Journal Classification (ASJC) codes

Health(social science)

Access to Document

10.1300/J381v10n04_09

Cite this

@article{f1c94223e94f4a198256b01dd03e641c,

title = "Alternative and complementary therapies: Glucosamine/Chondroitin: Still waiting for an answer",

abstract = "Results of the four-year study entitled the Glucosamine/chondroitin Arthritis Intervention Trial (GAIT) provided partial answers to those seeking relief from arthritis pain. Scientists will continue studying the efficacy of these substances as pain remedy and cartilage rejuvenator.",

author = "Dell, \{Esther Y.\} and Shultz, \{Suzanne M.\}",

note = "Funding Information: In November 2000, a four-year study entitled the Glucosamine/ chondroitin Arthritis Intervention Trial (GAIT) was begun. GAIT was jointly funded by the National Center for Complementary Medicine (NCCAM) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and was led by Daniel O. Clegg, MD, a rheumatologist from the University of Utah School of Medicine in Salt Lake City. It was conducted in 16 centers throughout the United States. Dr. Clegg noted in a press release in February 2006 that the goal “was to assess whether glucosamine and chondroitin sulfate, which we saw our osteoarthritis patients using, provided pain relief.”3 NIH Director Elias",

year = "2006",

doi = "10.1300/J381v10n04\_09",

language = "English (US)",

volume = "10",

pages = "95--101",

journal = "Journal of Consumer Health on the Internet",

issn = "1539-8285",

publisher = "Routledge",

number = "4",

}

TY - JOUR

T1 - Alternative and complementary therapies

T2 - Glucosamine/Chondroitin: Still waiting for an answer

AU - Dell, Esther Y.

AU - Shultz, Suzanne M.

N1 - Funding Information: In November 2000, a four-year study entitled the Glucosamine/ chondroitin Arthritis Intervention Trial (GAIT) was begun. GAIT was jointly funded by the National Center for Complementary Medicine (NCCAM) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and was led by Daniel O. Clegg, MD, a rheumatologist from the University of Utah School of Medicine in Salt Lake City. It was conducted in 16 centers throughout the United States. Dr. Clegg noted in a press release in February 2006 that the goal “was to assess whether glucosamine and chondroitin sulfate, which we saw our osteoarthritis patients using, provided pain relief.”3 NIH Director Elias

PY - 2006

Y1 - 2006

N2 - Results of the four-year study entitled the Glucosamine/chondroitin Arthritis Intervention Trial (GAIT) provided partial answers to those seeking relief from arthritis pain. Scientists will continue studying the efficacy of these substances as pain remedy and cartilage rejuvenator.

AB - Results of the four-year study entitled the Glucosamine/chondroitin Arthritis Intervention Trial (GAIT) provided partial answers to those seeking relief from arthritis pain. Scientists will continue studying the efficacy of these substances as pain remedy and cartilage rejuvenator.

UR - https://www.scopus.com/pages/publications/33751529498

UR - https://www.scopus.com/pages/publications/33751529498#tab=citedBy

U2 - 10.1300/J381v10n04_09

DO - 10.1300/J381v10n04_09

M3 - Article

AN - SCOPUS:33751529498

SN - 1539-8285

VL - 10

SP - 95

EP - 101

JO - Journal of Consumer Health on the Internet

JF - Journal of Consumer Health on the Internet

IS - 4

ER -

Alternative and complementary therapies: Glucosamine/Chondroitin: Still waiting for an answer

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this